Submitted by William D. Leslie, MD
University of Manitoba, Manitoba, Canada
A 65 year old white woman was referred for baseline BMD assessment due to high dose systemic glucocorticoid therapy. Her height was 63.2”, weight 196 lbs, and there was no history of previous fracture.
Both hips were scanned.
- What is(are)the most salient visual finding(s)?
- What is the best course for determining diagnosis and fracture risk in this patient?